Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Growth and Tolerance in New Born Fed Formula Supplemented With Alpha-Lactalbumin and Containing a Symbiotic

NCT00920166 is registered in ClinicalTrials.gov with Sodilac as lead sponsor.

NCT NCT00920166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00920166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Growth and Tolerance in New Born Fed Formula Supplemented With Alpha-Lactalbumin and Containing a Symbiotic
Lead sponsor
Sodilac
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2007
Completion date
March 31, 2008
Enrollment
97 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

growth